Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter CSL Limited has announced the ...

CSL (AU:CSL) has released an update. CSL Limited is hosting its 2024 Research & Development Investor Briefing, offering investors insights into the company’s latest innovations and strategic direction ...

After shocking investors in 2025, CSL shares may be setting up for a comeback. Here’s why 2026 could look better. The post ...

CSL Limited operates in the biotechnology industry, specializing in the development and manufacturing of innovative biotherapies and influenza vaccines. The company is a global leader in ...

CSL (AU:CSL) has released an update. CSL Limited has announced the issuance of 1,454 unquoted equity securities, indicating a strategic move to bolster its financial structure. This development could ...

Jefferies analyst David Stanton maintained a Buy rating on CSL (CMXHF – Research Report) on January 17 and set a price target of A$341.00. The company’s shares closed last Friday at $163.15. Discover ...

Australia’s largest drugmaker CSL Ltd. is committing roughly $1.5 billion to expand its US manufacturing footprint, joining a wave of pharmaceutical giants doubling down on American production. The ...

CSL Ltd.’s stock tumbled 16.88% on the news that it plans to cut 3,000 jobs and to hive off its Seqirus vaccine unit in a cost-cutting measure to save more than $500 million per year over the next ...